HomeAVXL • NASDAQ
add
Anavex Life Sciences Corp
Previous close
$3.92
Day range
$3.91 - $4.18
Year range
$2.86 - $13.99
Market cap
364.20M USD
Avg Volume
1.50M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.75M | -48.79% |
Net income | -5.68M | 53.09% |
Net profit margin | — | — |
Earnings per share | -0.06 | 57.14% |
EBITDA | — | — |
Effective tax rate | -0.32% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.75M | 9.09% |
Total assets | 132.99M | 7.21% |
Total liabilities | 6.37M | -51.47% |
Total equity | 126.62M | — |
Shares outstanding | 92.67M | — |
Price to book | 2.86 | — |
Return on assets | -14.25% | — |
Return on capital | -15.24% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.68M | 53.09% |
Cash from operations | -7.15M | 41.00% |
Cash from investing | — | — |
Cash from financing | 36.32M | 5,030.37% |
Net change in cash | 29.17M | 355.63% |
Free cash flow | -5.69M | 31.02% |
About
Founded
2004
Headquarters
Website
Employees
34
